Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2021-12-22 00:00:00 ET · period of report 2021-12-20 · accession 0001562180-21-007866 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-22 | 2021-12-20+ | SNDX | Legault Pierre | Dir | S - Sale+OE | $21.56 | -44.0K | 16.0K | -73% | -$948.4K |
| DM | 2021-12-22 | 2021-12-20+ | SNDX | Legault Pierre | Dir | M - OptEx | $7.52 | +44.0K | 40.0K | New | +$330.7K |
| DM | 2021-12-22 | 2021-12-20+ | SNDX | Legault Pierre | Dir | M - OptEx | $0.00 | -44.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-20 | S | D | 20,000 | $21.01 | 16,000 | D | — | — | (F2) The sale prices ranged from $21.00 to $21.0238. |
| 2 | Common | Common Stock | 2021-12-22 | S | D | 24,000 | $22.01 | 16,000 | D | — | — | (F3) The sale prices ranged from $22.00 to $22.02. |
| 3 | Common | Common Stock | 2021-12-20 | M | A | 20,000 | $7.08 | 36,000 | D | — | — | |
| 4 | Common | Common Stock | 2021-12-22 | M | A | 24,000 | $7.88 | 40,000 | D | — | — | |
| 5 | Derivative | Stock Options (Right to buy) | 2021-12-22 | M | D | 24,000 | $0.00 | 0 | D | $7.88 · — to 2029-06-10 | 24,000 Common Stock | (F4) This option is fully vested. |
| 6 | Derivative | Stock Options (Right to buy) | 2021-12-20 | M | D | 20,000 | $0.00 | 0 | D | $7.08 · — to 2027-01-04 | 20,000 Common Stock | (F4) This option is fully vested. |